FIELD: medicine.
SUBSTANCE: pharmaceutical agent is developed as a solution for injection containing 1-isonicotyl-2-glucosylhydrazone dehydrate (isoglucosyl) concentrated 0.1% to 10% as an active principle, and pharmaceutically acceptable carrier - water for injection.
EFFECT: high antituberculous activity and low toxicity.
4 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTITUBERCULOUS TABLET | 2007 |
|
RU2363475C2 |
SUPPOSITORY FOR TUBERCULOSIS TREATMENT | 2007 |
|
RU2363474C2 |
METHOD FOR PRODUCING POLYMERIC COMPLEX | 2010 |
|
RU2435611C1 |
METHOD FOR PRODUCING POLYMER CONJUGATE OF ISONICOTINIC ACID HYDRAZONE | 2010 |
|
RU2454226C1 |
PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
Authors
Dates
2009-06-20—Published
2007-08-31—Filed